New antibiotic shows promise in fighting tuberculosis

Cure­Vac, once a play­er in the Covid-19 vac­cine race, an­nounced that it plans to re­duce costs across the com­pa­ny. It said Wednes­day that it en­act­ed

Car­mot Ther­a­peu­tics has filed to go pub­lic in a chilly en­vi­ron­ment for new list­ings, but the obe­si­ty biotech’s place in one of drug de­vel­op­ment’s hottest

A sub­ur­ban Chica­go man who used in­sid­er in­for­ma­tion he got from his spouse, who worked at Ar­ray Bio­Phar­ma, to make near­ly $100,000 from buy­ing and